Amlodipine and Diphenhydramine Interaction: Safety, Risks, and Clinical Guidance

Updated May 26, 2026

Image: HealthRX.com clinical image

HealthRX.com quick answer. Amlodipine (brand name Norvasc, a dihydropyridine calcium channel blocker) and diphenhydramine (brand name Benadryl, a first-generation antihistamine) are not contraindicated together, and most healthy adults can take an occasional standard dose of each without a dangerous event. The interaction that drug interaction checkers flag as "moderate" is mostly pharmacodynamic: both drugs can lower blood pressure and both can cause sedation, so the combined effect can be larger than either drug alone. The pharmacokinetic piece, diphenhydramine's inhibition of the CYP2D6 enzyme, is a minor contributor because amlodipine is cleared mainly through a different enzyme, CYP3A4. The people who need real caution are older adults, anyone already close to symptomatic low blood pressure, and anyone taking other sedating or anticholinergic medications.

At a glance

Interaction severity, per commercial interaction databases / typically listed as moderate
Documented pharmacokinetic pathway / diphenhydramine inhibits CYP2D6; amlodipine's major clearance route is CYP3A4, with CYP2D6 playing only a minor role
Main clinical concern / additive blood pressure lowering plus additive sedation, not a metabolic interaction
Anticholinergic activity / diphenhydramine has substantial anticholinergic activity; amlodipine has essentially none
Population needing the most caution / adults 65 and older, and anyone on multiple blood-pressure-lowering or sedating medications
FDA contraindication between the two drugs / none identified
What requires verification / the specific magnitude of blood pressure change and any precise CYP2D6 exposure percentage for this exact drug pair

Direct answer

Amlodipine and diphenhydramine can usually be taken together for occasional, short-term use in adults with well-controlled blood pressure and no other sedating medications on board. The combination is flagged as a moderate interaction because the two drugs share overlapping side effects, lower blood pressure and cause drowsiness, not because there is a dangerous metabolic clash. Regulatory labeling for each drug does not list the other as a contraindication; the caution comes from general warnings about combining antihypertensives with other blood-pressure-lowering agents and from geriatric prescribing guidance that discourages diphenhydramine in older adults. The practical question for most readers is not "is this combination allowed" but "does my current blood pressure, age, and medication list leave enough margin to absorb an added drop in pressure and an added dose of sedation."

Two different drugs, two different jobs

Amlodipine is a long-acting dihydropyridine calcium channel blocker approved for hypertension and chronic stable angina. It works by relaxing vascular smooth muscle, and its long elimination half-life (commonly cited in the 30 to 50 hour range in prescribing information) means its blood-pressure-lowering effect is steady rather than a sharp peak-and-trough pattern.

Diphenhydramine is a first-generation H1-antihistamine sold over the counter as Benadryl and in many combination cold, allergy, and sleep products. It blocks histamine receptors and also has meaningful anticholinergic and central nervous system depressant activity, which is why it causes drowsiness and is marketed as a sleep aid despite that not being its primary approved indication.

These are unrelated drug classes with unrelated primary mechanisms. The interaction concern exists at the margins: a shared side effect profile and a minor shared metabolic pathway.

What is established

The clearest, best-supported facts about this pair:

Diphenhydramine is a recognized inhibitor of the CYP2D6 enzyme. This is well documented pharmacology for diphenhydramine generally, independent of amlodipine specifically.
Amlodipine's major metabolic pathway is CYP3A4, with only a minor contribution from CYP2D6. Strong CYP3A4 inhibitors (macrolide antibiotics, certain antifungals, protease inhibitors) are the interactions that meaningfully raise amlodipine blood levels, not CYP2D6 inhibitors.
Diphenhydramine carries a well-documented risk of sedation, dizziness, and anticholinergic effects (dry mouth, constipation, urinary retention, blurred vision, confusion), and this risk is dose-related and greater in older adults.
The American Geriatrics Society Beers Criteria, a widely used guideline for prescribing in older adults, identifies diphenhydramine as a medication to avoid in patients 65 and older because of anticholinergic burden, sedation, and fall risk. This guidance is about diphenhydramine on its own; it applies with added force when the patient is also taking an antihypertensive, because the fall risk pathway (orthostatic drop plus sedation) is compounded.
Neither the amlodipine product labeling nor the diphenhydramine over-the-counter Drug Facts label lists the other drug as contraindicated. The diphenhydramine label carries a general caution to check with a doctor before use if the patient has high blood pressure, which is a standard first-generation antihistamine precaution rather than a specific interaction warning.

What is pharmacologically plausible but not firmly quantified for this pair

It is biologically plausible that in a patient who is a CYP2D6 poor metabolizer, or who is taking another CYP2D6 substrate, diphenhydramine's enzyme inhibition could modestly raise the small CYP2D6-dependent fraction of amlodipine clearance and produce a slightly higher amlodipine level. It is also plausible that the additive vasodilation from diphenhydramine could produce a measurable, if modest, extra drop in blood pressure when layered on top of amlodipine, particularly in older adults or those with baseline low-normal pressure.

Earlier drafts of interaction pages like this one often cite a specific numeric effect size, for example a stated few-mmHg average blood pressure drop from a named cohort study, or a stated percentage increase in a co-administered drug's exposure from a named pharmacokinetic trial. Those specific figures could not be verified against a retrievable, matching primary source for this draft. Rather than restate an unverified number as though it were established, the honest position is: an additive hypotensive effect and a minor pharmacokinetic interaction are pharmacologically plausible and consistent with each drug's known individual profile, but the precise magnitude of the combined effect in a general adult population has not been confirmed here against a specific trial and should be treated as unquantified pending verification against the primary literature.

What is not established

There is no basis in FDA labeling or in the material reviewed for this page to call this a dangerous or contraindicated combination for a typical adult using standard over-the-counter diphenhydramine doses occasionally. There is also no basis here to state a specific numeric increase in amlodipine blood levels caused by diphenhydramine, or a specific numeric average blood pressure drop from the combination. Any such figure should be treated as unverified until confirmed against a named, retrievable study.

Evidence-status interaction assessment

Claim	Status	Basis	What to verify before relying on it clinically
Diphenhydramine inhibits CYP2D6	Established	General pharmacology of diphenhydramine	Not amlodipine-specific; confirms mechanism exists
Amlodipine is cleared mainly by CYP3A4, minimally by CYP2D6	Established	Amlodipine prescribing information and general pharmacokinetic literature	Confirms CYP2D6 inhibition has limited leverage on amlodipine levels
Diphenhydramine causes sedation and anticholinergic effects, worse in older adults	Established	Beers Criteria and general antihistamine pharmacology	Applies regardless of amlodipine co-use
No FDA contraindication between amlodipine and diphenhydramine	Established	Product labeling for each drug	Labeling reviewed does not equal an exhaustive interaction study
Combination produces additive blood pressure lowering	Plausible, directionally supported by mechanism	Each drug's individual hemodynamic profile	No verified pooled or trial-level effect size for the combination confirmed in this review
CYP2D6 poor metabolizers see a clinically meaningful rise in amlodipine exposure with diphenhydramine	Plausible, mechanistically coherent	Minor CYP2D6 role in amlodipine clearance	No confirmed pharmacokinetic study of this specific pair located; genotype-specific data would be needed
A specific mmHg drop or percentage AUC increase for this pair	Not established in this review	Not sourced to a verifiable, matching study	Requires a named, checkable clinical trial or pharmacokinetic study before quoting a number
Combined anticholinergic load with other drugs (oxybutynin, amitriptyline, meclizine) raises cognitive and fall risk	Established as a general anticholinergic burden principle	Anticholinergic burden literature and Beers Criteria	Amlodipine itself contributes no anticholinergic load; the risk comes from diphenhydramine plus other agents

Who needs more caution

Adults 65 and older. This is the group guideline bodies specifically flag for diphenhydramine avoidance, independent of amlodipine. Slower drug clearance, higher baseline fall risk, and greater sensitivity to both sedation and orthostatic blood pressure drops make this combination worth a conversation with a prescriber or pharmacist rather than casual over-the-counter use.

Anyone on more than one blood-pressure-lowering medication. Less hemodynamic reserve means an added vasodilator, even a mild one, is more likely to produce symptomatic dizziness or lightheadedness on standing.

Anyone already taking another anticholinergic or sedating medication. Overactive bladder drugs, certain antidepressants, and other antihistamines add to diphenhydramine's own anticholinergic and sedative load. The clinical signal to watch for is new confusion, dry mouth, constipation, or urinary difficulty, which can be mistaken for an amlodipine side effect when the real driver is cumulative anticholinergic burden.

People whose baseline blood pressure is already low-normal. A patient with a systolic pressure comfortably above 125 mmHg on amlodipine has more room to absorb an added vasodilator than a patient whose systolic pressure runs near 110 mmHg.

Practical monitoring points

Check blood pressure, ideally seated and then standing, after starting diphenhydramine while on amlodipine, especially the first time. A notable drop on standing, or symptomatic dizziness, is a reason to stop the diphenhydramine and discuss alternatives rather than push through it.
Watch for new drowsiness beyond what is expected from diphenhydramine alone, since amlodipine itself is not typically sedating and added sedation may reflect the combined effect or another contributing medication.
Watch for anticholinergic symptoms, dry mouth, constipation, blurred vision, urinary retention, or confusion, particularly in older adults or anyone on other anticholinergic drugs. These symptoms should prompt a medication review rather than a change to the amlodipine dose.
Do not stop amlodipine abruptly because of a diphenhydramine-related side effect. Abrupt discontinuation of an antihypertensive carries its own risk. If a problem arises, the diphenhydramine is the medication to reconsider first, in consultation with a prescriber or pharmacist.
Limit diphenhydramine to short-term, as-needed use. Following the standard over-the-counter labeling limits on dose and duration reduces the chance of steady-state accumulation, particularly relevant for anyone with reduced kidney or liver function.

Safer alternatives when an antihistamine is needed

Second-generation antihistamines, cetirizine, loratadine, and fexofenadine, have substantially less anticholinergic and sedative activity than diphenhydramine and are not known to meaningfully inhibit CYP2D6. For patients on amlodipine who need ongoing allergy control, these are the more conservative first choice, discussed with a pharmacist if there is any question about the specific product or combination formulation involved.

For patients using diphenhydramine specifically as a sleep aid, professional sleep medicine guidance generally does not favor antihistamine-based sleep aids for chronic insomnia, and cognitive behavioral therapy for insomnia is typically recommended as a first-line approach, with pharmacologic options discussed individually with a clinician when needed. This page does not make an individualized recommendation on sleep medication choice.

When to seek urgent care

Lightheadedness severe enough to cause a fall or near-fall, fainting, chest pain, a resting heart rate persistently above 100 to 120 beats per minute with symptoms, or new confusion that does not resolve should prompt urgent medical evaluation rather than waiting to see if it passes. These symptoms can have causes unrelated to this drug combination, and a clinician needs to sort that out directly.

Evidence boundary summary

Established: diphenhydramine inhibits CYP2D6 and has substantial sedative and anticholinergic effects; amlodipine's major clearance pathway is CYP3A4 with only minor CYP2D6 involvement; diphenhydramine is flagged as inappropriate for older adults by geriatric prescribing guidelines; neither drug's FDA labeling contraindicates the other. Plausible but not confirmed here with a specific number: a modest additive blood pressure drop, and a modest rise in amlodipine exposure in CYP2D6 poor metabolizers. Not established: any precise magnitude of blood pressure change or exposure increase specific to this drug pair, and any claim that this is a dangerous or high-severity interaction for typical short-term, standard-dose use in a healthy adult.

Frequently asked questions

Can I take amlodipine with diphenhydramine?

For most adults, occasional standard-dose use of both is not considered dangerous, but it is treated as a moderate interaction because both drugs can lower blood pressure and cause sedation. People over 65, those on multiple blood pressure medications, or those with low-normal blood pressure should check with a prescriber or pharmacist first.

Does diphenhydramine lower blood pressure?

Diphenhydramine can produce mild blood pressure lowering through peripheral vasodilation and its anticholinergic and sedative effects. This is generally modest at standard over-the-counter doses but can add to the effect of an antihypertensive like amlodipine, particularly in older adults.

Is diphenhydramine safe for someone taking amlodipine long-term?

Occasional short-term use is generally considered lower risk than daily or long-term use. Geriatric prescribing guidelines recommend avoiding diphenhydramine in adults 65 and older regardless of what other medications they take, because of its sedative and anticholinergic burden.

What is a safer antihistamine to use with amlodipine?

Second-generation antihistamines such as cetirizine, loratadine, and fexofenadine have much less sedative and anticholinergic activity than diphenhydramine and are generally the more conservative choice for someone on regular antihypertensive therapy.

Should I stop taking amlodipine if I need to use Benadryl?

No, do not stop an antihypertensive without medical advice. Abruptly stopping amlodipine carries its own risks. If a problem occurs, reconsidering the diphenhydramine, not the amlodipine, is usually the appropriate first step, and that decision should involve a prescriber or pharmacist.

References and further reading

The prior version of this page cited a series of specific PubMed identifiers and a specific FDA label URL for numeric claims (blood pressure change magnitude, CYP2D6 exposure percentages, enzyme inhibition studies). Those identifiers could not be confirmed as matching, retrievable primary sources during this review and have been removed rather than carried forward as unverified citations. Readers and reviewing clinicians should consult:

FDA drug safety and availability resources: https://www.fda.gov/drugs/drug-safety-and-availability
The current FDA-approved prescribing information for amlodipine (Norvasc) and the over-the-counter Drug Facts label for diphenhydramine, both searchable through FDA's official drug label database
The American Geriatrics Society Beers Criteria for potentially inappropriate medication use in older adults, for the diphenhydramine-in-elderly recommendation

This article is intended for general education and does not replace an individualized medication review by a prescriber or pharmacist who has your full medication list, blood pressure history, and kidney and liver function status.